AT9283在制备抗猴痘病毒药物中的应用
By applying AT9283 to monkeypox virus drugs, the virus invasion, replication and release were inhibited, solving the problem of the lack of specific treatments for monkeypox virus and achieving virus inhibition at low toxic concentrations, providing a basis for the development of new drugs.
CN122097378BActive Publication Date: 2026-07-17XIANGYANG CENT HOSPITAL
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- XIANGYANG CENT HOSPITAL
- Filing Date
- 2026-04-30
- Publication Date
- 2026-07-17
Smart Images
Figure CN122097378B_ABST
Abstract
本发明提出了AT9283在制备抗猴痘病毒药物中的应用。通过体外实验验证了多靶点激酶抑制剂AT9283能够在低毒性浓度下有效抑制猴痘病毒的复制，揭示了AT9283作为抗猴痘病毒药物的新用途，为开发新型、安全、有效的猴痘治疗药物提供了重要依据和候选化合物。
Need to check novelty before this filing date? Find Prior Art